Subtopic Deep Dive
Epidemiology and Risk Factors of PAD
Research Guide
What is Epidemiology and Risk Factors of PAD?
Epidemiology and Risk Factors of PAD examines the global prevalence, incidence, and modifiable risk factors such as smoking, diabetes, dyslipidemia, and chronic kidney disease associated with peripheral artery disease.
PAD affects over 230 million adults worldwide, with prevalence rising with age and strongly linked to traditional cardiovascular risks (Criqui and Aboyans, 2015; 1667 citations). Recent guidelines integrate updated epidemiological data for risk stratification (Aboyans et al., 2017; 929 citations). Studies model population attributable risks and temporal trends to inform screening (Criqui et al., 2021; 687 citations).
Why It Matters
Epidemiological data reveal PAD underdiagnosis in 90% of cases, driving public health initiatives for ABI screening in high-risk groups like diabetics (Criqui and Aboyans, 2015). Risk factor modeling quantifies smoking's 50% attributable risk, guiding cessation programs and reducing amputation rates by 20% in targeted interventions (Aday and Matsushita, 2021). In CKD patients, PAD prevalence exceeds 50%, informing dialysis center protocols (Rajagopalan et al., 2006). These insights shape ESC guidelines for early detection, lowering CV mortality (Aboyans et al., 2017).
Key Research Challenges
Underdiagnosis in Asymptomatic Cases
PAD remains undetected in most cases due to reliance on symptomatic presentation, with ABI screening underutilized (Criqui et al., 2021). Global prevalence surveys show inconsistencies across regions (Criqui and Aboyans, 2015). Standardization of diagnostic thresholds is needed.
Quantifying Population Attributable Risks
Modeling interactions between risks like diabetes and smoking requires longitudinal cohorts (Aday and Matsushita, 2021). Temporal trends vary by ethnicity, complicating projections (Criqui and Aboyans, 2015). Advanced statistical methods are essential for accuracy.
Risk Factor Heterogeneity in CKD
Medial calcification predominates in CKD, differing from atherosclerotic patterns elsewhere (Rocha-Singh et al., 2014). Prevalence exceeds 50% in ESRD, yet mechanisms are unclear (Rajagopalan et al., 2006). Targeted studies are lacking.
Essential Papers
2017 ESC Guidelines on the Diagnosis and Treatment of Peripheral Arterial Diseases, in collaboration with the European Society for Vascular Surgery (ESVS)
Jean‐Baptiste Ricco, Marie-Louise Bartelink, Martin Björck et al. · 2017 · European Heart Journal · 3.2K citations
Document covering atherosclerotic disease of extracranial carotid \nand vertebral, mesenteric, renal, upper and lower extremity arteries
Epidemiology of Peripheral Artery Disease
Michael H. Criqui, Victor Aboyans · 2015 · Circulation Research · 1.7K citations
New data on the epidemiology of peripheral artery disease (PAD) are available, and they should be integrated with previous data. We provide an updated, integrated overview of the epidemiology of PA...
Editor's Choice – 2017 ESC Guidelines on the Diagnosis and Treatment of Peripheral Arterial Diseases, in collaboration with the European Society for Vascular Surgery (ESVS)
Victor Aboyans, Jean‐Baptiste Ricco, Marie-Louise E.L. Bartelink et al. · 2017 · European Journal of Vascular and Endovascular Surgery · 929 citations
Rivaroxaban in Peripheral Artery Disease after Revascularization
Marc P. Bonaca, Rupert Bauersachs, Sonia S. Anand et al. · 2020 · New England Journal of Medicine · 917 citations
In patients with peripheral artery disease who had undergone lower-extremity revascularization, rivaroxaban at a dose of 2.5 mg twice daily plus aspirin was associated with a significantly lower in...
Society for Vascular Surgery practice guidelines for atherosclerotic occlusive disease of the lower extremities: Management of asymptomatic disease and claudication
Michael S. Conte, Frank B. Pomposelli, Daniel G. Clair et al. · 2015 · Journal of Vascular Surgery · 880 citations
Lower Extremity Peripheral Artery Disease: Contemporary Epidemiology, Management Gaps, and Future Directions: A Scientific Statement From the American Heart Association
Michael H. Criqui, Kunihiro Matsushita, Victor Aboyans et al. · 2021 · Circulation · 687 citations
Lower extremity peripheral artery disease (PAD) affects >230 million adults worldwide and is associated with increased risk of various adverse clinical outcomes (other cardiovascular diseases su...
Editor's Choice – European Society for Vascular Surgery (ESVS) 2022 Clinical Practice Guidelines on the Management of Chronic Venous Disease of the Lower Limbs
Marianne De Maeseneer, Stavros K. Kakkos, Thomas Aherne et al. · 2022 · European Journal of Vascular and Endovascular Surgery · 645 citations
Reading Guide
Foundational Papers
Start with Criqui and Aboyans (2015) for core epidemiology overview (1667 citations), then Rocha-Singh et al. (2014) for calcification risks in high-prevalence groups like CKD patients.
Recent Advances
Study Criqui et al. (2021; 687 citations) for contemporary gaps and Aday and Matsushita (2021; 509 citations) for polyvascular epidemiology advances.
Core Methods
ABI measurement (Potier et al., 2010), cohort risk modeling (Criqui and Aboyans, 2015), and guideline-integrated prevalence surveys (Aboyans et al., 2017).
How PapersFlow Helps You Research Epidemiology and Risk Factors of PAD
Discover & Search
Research Agent uses searchPapers for 'PAD epidemiology risk factors' yielding Criqui and Aboyans (2015), then citationGraph reveals 1667 citing papers including Criqui et al. (2021), and findSimilarPapers uncovers Aday and Matsushita (2021) on polyvascular risks.
Analyze & Verify
Analysis Agent applies readPaperContent to extract prevalence data from Criqui et al. (2021), verifyResponse with CoVe checks risk factor odds ratios against raw abstracts, and runPythonAnalysis performs meta-analysis on ABI thresholds using pandas for GRADE B evidence grading on smoking risks.
Synthesize & Write
Synthesis Agent detects gaps in CKD-specific risks via contradiction flagging between Rocha-Singh et al. (2014) and general cohorts, while Writing Agent uses latexEditText for risk model equations, latexSyncCitations for 10+ references, and latexCompile to generate a formatted review section with exportMermaid for prevalence trend diagrams.
Use Cases
"Model population attributable fraction of smoking for PAD using recent cohorts"
Research Agent → searchPapers → Analysis Agent → runPythonAnalysis (pandas cohort simulation from Criqui 2021 data) → outputs CSV of PAR estimates with 95% CIs.
"Draft LaTeX table of PAD risk factors from ESC guidelines"
Research Agent → exaSearch 'Aboyans 2017 PAD risks' → Synthesis Agent → gap detection → Writing Agent → latexEditText + latexSyncCitations + latexCompile → outputs compiled PDF table.
"Find GitHub repos analyzing PAD epidemiology datasets"
Research Agent → citationGraph on Criqui 2015 → Code Discovery (paperExtractUrls → paperFindGithubRepo → githubRepoInspect) → outputs repo with R scripts for ABI prevalence mapping.
Automated Workflows
Deep Research workflow conducts systematic review: searchPapers on 'PAD risk factors' → 50+ papers → DeepScan 7-step analysis with CoVe checkpoints on prevalence claims → structured report with GRADE scores. Theorizer generates hypotheses on diabetes-PAD interactions from Criqui et al. (2021) and Rocha-Singh et al. (2014), chaining gap detection to risk model simulations.
Frequently Asked Questions
What is the definition of Epidemiology and Risk Factors of PAD?
It studies global prevalence (230M+ cases) and risks like smoking (OR 2.5-4), diabetes, and dyslipidemia driving PAD (Criqui and Aboyans, 2015).
What are key methods in PAD epidemiology?
Ankle-brachial index (ABI <0.9) screening, cohort studies like CHARISMA, and modeling for population attributable risks (Aday and Matsushita, 2021).
What are foundational papers?
Criqui and Aboyans (2015; 1667 citations) integrates prevalence data; Rocha-Singh et al. (2014; 569 citations) details calcification risks in diabetes/CKD.
What are open problems?
Heterogeneous risks in low-income regions, longitudinal data on polyvascular disease, and calcification mechanisms beyond CKD (Criqui et al., 2021).
Research Peripheral Artery Disease Management with AI
PapersFlow provides specialized AI tools for your field researchers. Here are the most relevant for this topic:
AI Literature Review
Automate paper discovery and synthesis across 474M+ papers
Deep Research Reports
Multi-source evidence synthesis with counter-evidence
Paper Summarizer
Get structured summaries of any paper in seconds
AI Academic Writing
Write research papers with AI assistance and LaTeX support
Start Researching Epidemiology and Risk Factors of PAD with AI
Search 474M+ papers, run AI-powered literature reviews, and write with integrated citations — all in one workspace.